Skip to content
Agree.net – Lifestyle
Author:
Adcentrx Therapeutics
China NMPA Grants IND Clearance to Adcentrx Therapeutics’ ADRX-0405 STEAP1 ADC for the Treatment of Late-Stage Solid Tumors, Including Prostate Cancer
June 8, 2026